TRPV1 antagonists (Medifron/Grunenthal)

N/A

Report date: 2025/06/11 10:31:20
NME

Base Information

Drug NameTRPV1 antagonists (Medifron/Grunenthal)
Drug Alias NameVR1 antagonists (Digital Biotech/Grunenthal)vanilloid antagonists (Digital Biotech/Grunenthal)TRPV1 antagonists (Digital Biotech/Grunenthal)(S)-KMJ-372MK-271 +[8] 
ClassificationSmall molecules
Mechanisms of ActionVanilloid receptor antagonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsPainNeuralgiaCough
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDigital Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMedifronGrunenthal Gmbh
Inactive CompaniesDigital Biotech Co Ltd
Active IndicationsPainNeuralgiaCough
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A